Evidence map›Paper›PMID 31111870›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

The Predictive Performance of a Pneumonia Severity Score in Human Immunodeficiency Virus-negative Children Presenting to Hospital in 7 Low- and Middle-income Countries.

Katherine E Gallagher, Maria D Knoll, Chrissy Prosperi, Henry C Baggett, W Abdullah Brooks, Daniel R Feikin, Laura L Hammitt, Stephen R C Howie, Karen L Kotloff, Orin S Levine and 19 more

Open access · hybridAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 3 syntheses or guidelines pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Observational
  18. Observational
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors at 13 institutions in 11 countries.

Katherine E GallagherDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
Maria D KnollDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Chrissy ProsperiDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Henry C BaggettDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia.
W Abdullah BrooksDepartment of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Daniel R FeikinDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Laura L HammittDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Stephen R C HowieMedical Research Council Unit, Basse, The Gambia.
Karen L KotloffDivision of Infectious Disease and Tropical Pediatrics, Department of Pediatrics, Center for Vaccine Development, University of Maryland School of Medicine, Baltimore.
Orin S LevineDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Shabir A MadhiMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
David R MurdochDepartment of Pathology, University of Otago, Christchurch, New Zealand.
Katherine L O'BrienDepartment of International Health, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Donald M TheaDepartment of Global Health, Boston University School of Public Health, Massachusetts.
Juliet O AworiKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Vicky L BaillieMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
Bernard E EbrukeMedical Research Council Unit, Basse, The Gambia.
Doli GoswamiInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
Alice KamauKenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi.
Susan A MaloneyGlobal Disease Detection Center, Thailand Ministry of Public Health-US CDC Collaboration, Nonthaburi.
David P MooreMedical Research Council, Respiratory and Meningeal Pathogens Research Unit, Johannesburg, South Africa.
Lawrence MwananyandaCenter for Global Health and Development, Boston University School of Public Health, Massachusetts.
Emmanuel O OlutundeMedical Research Council Unit, Basse, The Gambia.
Phil SeidenbergCenter for Global Health and Development, Boston University School of Public Health, Massachusetts.
Seydou SissokoCentre pour le Développement des Vaccins, Bamako, Mali.
Mamadou SyllaCentre pour le Développement des Vaccins, Bamako, Mali.
Somsak ThamthitiwatGlobal Disease Detection Center, Thailand Ministry of Public Health-US CDC Collaboration, Nonthaburi.
Khalequ ZamanInternational Centre for Diarrhoeal Disease Research, Bangladesh, Dhaka and Matlab.
J Anthony G ScottDepartment of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, United Kingdom.
Johns Hopkins University · USBoston University · USKenya Medical Research Institute · KEUniversity of the Witwatersrand · ZACentre Pour le Développement des Vaccins-Mali · MLInternational Centre for Diarrhoeal Disease Research · BDMinistry of Public Health · THMRC Unit the Gambia · GMCanterbury Health Laboratories · NZCenters for Disease Control and Prevention · USLondon School of Hygiene & Tropical Medicine · GBUniversity of Auckland · NZUniversity of Maryland, Baltimore · US

Funding

Wellcome TrustWellcome Trust 098532
6 · The paper itself

Abstract

backgroundIn 2015, pneumonia remained the leading cause of mortality in children aged 1-59 months.

methodsData from 1802 human immunodeficiency virus (HIV)-negative children aged 1-59 months enrolled in the Pneumonia Etiology Research for Child Health (PERCH) study with severe or very severe pneumonia during 2011-2014 were used to build a parsimonious multivariable model predicting mortality using backwards stepwise logistic regression. The PERCH severity score, derived from model coefficients, was validated on a second, temporally discrete dataset of a further 1819 cases and compared to other available scores using the C statistic.

resultsPredictors of mortality, across 7 low- and middle-income countries, were age <1 year, female sex, ≥3 days of illness prior to presentation to hospital, low weight for height, unresponsiveness, deep breathing, hypoxemia, grunting, and the absence of cough. The model discriminated well between those who died and those who survived (C statistic = 0.84), but the predictive capacity of the PERCH 5-stratum score derived from the coefficients was moderate (C statistic = 0.76). The performance of the Respiratory Index of Severity in Children score was similar (C statistic = 0.76). The number of World Health Organization (WHO) danger signs demonstrated the highest discrimination (C statistic = 0.82; 1.5% died if no danger signs, 10% if 1 danger sign, and 33% if ≥2 danger signs).

conclusionsThe PERCH severity score could be used to interpret geographic variations in pneumonia mortality and etiology. The number of WHO danger signs on presentation to hospital could be the most useful of the currently available tools to aid clinical management of pneumonia.

Indexed as

Developing CountriesPneumoniaChildChild, PreschoolFemaleHIVHospitalsHumansInfantSeverity of Illness Indexpneumococcal diseasepneumoniaprognosis/prognostic scoresrespiratory diseaseseverity index

Identifiers

PMID31111870
PMCPMC7610754
OpenAlexW2946574793

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.